A purple and pink letter v on a white background.
May 22, 2026

Integrating Radiotherapy into Skin Cancer Care: Insights for Dermatology Clinics

Skin cancer continues to be one of the most commonly diagnosed cancers globally. With continuous advancements in treatment methods, dermatologists are constantly seeking more effective solutions. Skin cancer radiotherapy has emerged as an important addition to the clinical toolkit. This treatment method opens up new pathways for certain types of skin cancer, especially for tumors that are difficult to treat with surgery alone. Today, radiotherapy, combined with other therapeutic approaches, is transforming how skin cancer is managed, leading to improved patient outcomes. 

 

The role of facial treatment machines has expanded beyond cosmetic treatments to include technologies that assist in skin cancer care. These tools complement radiotherapy, aiding skin healing and supporting efficient care during treatment. 

 

The Role of Radiotherapy in Skin Cancer Treatment 


Radiotherapy, specifically designed for skin cancer, involves using high-energy rays, such as X-rays or electrons, to destroy cancer cells. This treatment is often utilized when a skin tumor is too large or located in an area that is hard to surgically remove. While surgery remains the primary approach for basal and squamous cell carcinomas, radiotherapy is invaluable when surgery is not an option or when additional treatment is necessary. 


For example, radiotherapy can be used after surgery to eliminate small cancer cells that may not be visible, reducing the risk of recurrence. This approach is known as adjuvant treatment. It can also be helpful in treating advanced melanoma or when skin cancer has spread to other organs or lymph nodes. 

 

When is Radiotherapy Used in Skin Cancer Treatment? 


Radiotherapy is most commonly employed when a tumor cannot be surgically removed or if a patient is not suitable for surgery. For large skin tumors, radiotherapy offers a focused approach to destroy cancer while minimizing harm to healthy tissue. For certain skin cancers like melanoma, radiotherapy can be used as a primary treatment when surgical removal is not an option. 

 

Radiotherapy is also used in conjunction with other therapies. After surgery, it can be applied to target any remaining cancer cells, offering a more complete treatment plan. This method is often recommended for patients with a higher risk of recurrence. 

 

Skin Cancer Treatment Guidelines and the Role of Radiotherapy 


Following the proper Skin Cancer Treatment Guidelines is important for dermatologists to determine the best course of treatment for each patient. These guidelines detail when and how radiotherapy should be included in a treatment plan. For instance, patients with basal or squamous cell carcinoma may undergo surgery followed by radiotherapy to minimize the risk of recurrence. In more advanced melanoma stages, radiotherapy can help control the disease and manage symptoms. 

 

The choice to use radiotherapy depends on various factors, including the type of skin cancer, tumor location, patient health, and personal preferences. As an adjunct therapy, radiotherapy offers dermatologists a flexible option for customizing treatment plans, ultimately improving patient care. 

 

Different Types of Radiotherapy for Skin Cancer


Radiotherapy can be delivered in different ways, with two main types: external radiation therapy and brachytherapy. 

 

External Radiation Therapy 

 

In external radiation therapy, radiation is directed at the skin tumor from outside the body using a machine. This method uses X-rays or electron beams focused on the cancerous area. External radiation is typically used for larger tumors or those located on areas of the body that are more accessible. The procedure is painless, and each session is relatively brief. 

 

Brachytherapy 

 

Brachytherapy involves placing a radioactive source directly onto or near the tumor. This method is used for tumors located in areas such as the head or neck. It allows for more precise treatment, minimizing the exposure of surrounding healthy tissues. Brachytherapy is often completed in fewer sessions, making it a more convenient option for patients seeking alternatives to surgery. 

 

Side Effects and Considerations of Radiotherapy for Skin Cancer


Like any medical treatment, radiotherapy carries potential risks, although they are usually limited to the treated area. These risks may include skin irritation, redness, and hair loss. In rare cases, long-term complications can involve changes in skin texture or the development of secondary cancers in the treated area. These concerns are particularly relevant for younger patients or those receiving high doses of radiation. 

 

However, radiotherapy is generally considered safe when used correctly. Dermatologists weigh the benefits and risks carefully, making sure patients are well-informed and involved in the decision-making process. 

 

The Future of Skin Cancer Treatment: AI and Radiotherapy Integration 


Looking forward, artificial intelligence (AI) has the potential to further refine the role of radiotherapy in skin cancer treatment. AI-driven technologies can assist in precisely targeting tumors, ensuring that radiation is delivered to the right areas while minimizing damage to surrounding tissues. These innovations could enhance the accuracy and efficiency of radiotherapy, expanding its role in skin cancer management. 

 

As AI and advanced technologies continue to evolve, dermatologists will have more tools to diagnose and treat skin cancer with greater precision. These developments offer new hope for patients, improving the quality and speed of care. 

 

Improving Patient Outcomes with Personalized Treatment Plans 


The integration of radiotherapy, cutting-edge technologies, and personalized care plans is setting a new standard for skin cancer treatment. By tailoring treatments to each patient’s unique needs, dermatologists can offer the most optimal care possible. 

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Learn how skin cancer patient education can improve prevention, early detection, and treatment outcomes in dermatology clinics.